Compare · EUCR vs MLEC
EUCR vs MLEC
Side-by-side comparison of Eucrates Biomedical Acquisition Corp. (EUCR) and Moolec Science SA (MLEC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUCR and MLEC operate in Blank Checks (Finance), so they compete in similar markets.
- MLEC carries a market cap of $1.2M.
- MLEC has hit the wire 3 times in the past 4 weeks while EUCR has been quiet.
- MLEC has more recent analyst coverage (1 ratings vs 0 for EUCR).
EUCR
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
Latest MLEC
- Moolec Science SA in Voluntary Liquidation Announces Receipt of Nasdaq Delisting Determination Following Approval of Voluntary Liquidation
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States
- SEC Form 6-K filed by Moolec Science SA